Nauck MA, DAlessio DA (2022) Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regarding glycaemic control and body weight reduction
It's a subtle but profound difference
Common reasons include: Side effects particularly persistent gastrointestinal symptoms such as nausea, vomiting, diarrhoea, or abdominal discomfort that do not resolve with time or dose adjustment Inadequate glycaemic control if your HbA1c remains above target despite optimal dosing, your clinician may recommend switching to an alternative therapy Access issues local NHS formulary restrictions may affect availability of the medication Achievement of treatment goals in some cases, significant lifestyle modifications and weight loss may allow for de-escalation of diabetes medications Pregnancy planning semaglutide should be discontinued at least 2 months before a planned pregnancy and is not recommended during pregnancy or breastfeeding [1] [5] Development of certain conditions such as pancreatitis, gallbladder disease, or severe gastrointestinal disorders like gastroparesis It is essential to discuss any decision to stop Rybelsus with your GP or diabetes specialist team
Chronic Dis
Probiotic Blend (500 million AFU)(Clostridium butyricum WB-STR-0006 Akkermansia muciniphila WB-STR-0001 Bifidobacterium infantis) 20 mg Chicory Inulin 211 mg Other Ingredients: microcrystalline cellulose, hypromellose (vegetarian capsule), silica Pendulum GLP-1 Probiotic Pro increases GLP-1 naturally* *Based on preclinical studies Formulated with: Akkermansia muciniphila generates the postbiotics propionate and p9 which induce GLP-1 production
We do not provide any advice on the usage of these products as UK Law prevents this
